DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Huang RY, Rahman R, Ballman KV. et al.
The impact of T2/FLAIR evaluation per RANO criteria on response assessment of recurrent glioblastoma patients treated with bevacizumab.
Clin Cancer Res 2016;
22: 575-581
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.